Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Spring Sale
Enjoy this offer
* See conditions under "Our services"

Valuation: Bayer AG

Capitalization 35.75B 41.46B 32.27B 30.97B 56.47B 3,811B 59.09B 382B 153B 1,827B 156B 152B 6,535B P/E ratio 2026 *
29.5x
P/E ratio 2027 * 12.3x
Enterprise value 68.11B 78.99B 61.48B 58.99B 108B 7,259B 113B 727B 291B 3,481B 296B 290B 12,451B EV / Sales 2026 *
1.5x
EV / Sales 2027 * 1.38x
Free-Float
100%
Yield 2026 *
0.63%
Yield 2027 * 2.37%
1 day+2.12%
1 week-9.15%
Current month-12.18%
1 month-20.28%
3 months+1.61%
6 months+30.67%
Current year-0.31%
1 week 35.2
Extreme 35.2
39.77
1 month 35.2
Extreme 35.2
49.78
Current year 35.2
Extreme 35.2
49.78
1 year 18.38
Extreme 18.378
49.78
3 years 18.38
Extreme 18.378
61.91
5 years 18.38
Extreme 18.378
67.99
10 years 18.38
Extreme 18.378
123.9
Manager TitleAgeSince
Chief Executive Officer 59 01/06/2023
Director of Finance/CFO 56 01/06/2018
Chief Tech/Sci/R&D Officer 59 01/02/2021
Director TitleAgeSince
Director/Board Member 69 01/04/2002
Director/Board Member 55 01/04/2012
Director/Board Member 66 01/04/2022
Change 5d. change 1-year change 3-years change Capi.($)
+2.18%-9.15%+56.63%-36.41% 41.46B
-0.02%-2.99%+19.02%+211.68% 885B
+0.27%-3.32%+43.30%+58.90% 579B
-1.79%-2.85%+5.04%+54.46% 407B
-3.24%-9.62%+6.70%+24.20% 350B
+1.26%-4.49%+22.43%+64.38% 302B
-1.48%-6.91%+19.90%+30.67% 301B
-0.62%-5.84%+20.05%+6.25% 286B
-0.28%-4.80%+12.16%+62.62% 199B
+0.68%-3.89%+23.02%+82.63% 179B
Average -0.32%-5.73%+22.83%+55.94% 353.02B
Weighted average by Cap. -0.53%-4.97%+20.88%+87.31%

Financials

2026 *2027 *
Net sales 45.42B 52.68B 41B 39.34B 71.75B 4,842B 75.08B 485B 194B 2,322B 198B 194B 8,304B 46.84B 54.33B 42.29B 40.57B 73.99B 4,993B 77.43B 500B 200B 2,394B 204B 200B 8,563B
Net income 1.63B 1.89B 1.47B 1.41B 2.58B 174B 2.7B 17.42B 6.98B 83.43B 7.1B 6.95B 298B 3.07B 3.56B 2.77B 2.66B 4.85B 327B 5.08B 32.79B 13.14B 157B 13.37B 13.09B 562B
Net Debt 32.36B 37.53B 29.21B 28.03B 51.11B 3,449B 53.49B 345B 138B 1,654B 141B 138B 5,915B 28.98B 33.61B 26.16B 25.1B 45.77B 3,089B 47.9B 309B 124B 1,481B 126B 123B 5,297B
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
87,280
Date Price Change Volume
09/03/26 36.90 +1.39% 1,640,985
06/03/26 36.39 -3.67% 4,827,217
05/03/26 37.78 +1.00% 5,145,542
04/03/26 37.40 -2.38% 9,110,207
03/03/26 38.31 -5.66% 7,239,455
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
36.39EUR
Average target price
45.04EUR
Spread / Average Target
+23.77%

Quarterly revenue - Rate of surprise

SPRING SALE -40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW